Viewing StudyNCT05861830



Ignite Creation Date: 2024-05-06 @ 7:01 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05861830
Status: RECRUITING
Last Update Posted: 2024-03-12
First Post: 2023-05-07

Brief Title: Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK46 Inhibitor Failure DAWNA-FES
Sponsor: Peking Union Medical College Hospital
Organization: Peking Union Medical College Hospital

Conditions & Keywords Data

Conditions:
Name
Advanced Breast Cancer
Keywords: